眼部药物递送。药代动力学考量。 - Suppr

Suppr

超能文献

Ocular drug delivery. Pharmacokinetic considerations.

作者信息

Schoenwald R D

机构信息

University of Iowa, College of Pharmacy, Iowa City.

出版信息

Clin Pharmacokinet. 1990 Apr;18(4):255-69. doi: 10.2165/00003088-199018040-00001.

DOI:10.2165/00003088-199018040-00001

PMID:2182264

Abstract

摘要

相似文献

Ocular drug delivery. Pharmacokinetic considerations.眼部药物递送。药代动力学考量。

Clin Pharmacokinet. 1990 Apr;18(4):255-69. doi: 10.2165/00003088-199018040-00001.

A New Vision for the Eye: Unmet Ocular Drug Delivery Needs.眼部新视野：未满足的眼部药物递送需求。

Pharm Res. 2015 Sep;32(9):2814-23. doi: 10.1007/s11095-015-1717-z. Epub 2015 Jun 9.

Ocular Therapeutics: Drug Delivery and Pharmacology.眼部治疗学：药物递送与药理学

Mol Pharm. 2016 Sep 6;13(9):2875-6. doi: 10.1021/acs.molpharmaceut.6b00703.

Challenges and obstacles of ocular pharmacokinetics and drug delivery.眼部药代动力学与药物递送的挑战和障碍

Adv Drug Deliv Rev. 2006 Nov 15;58(11):1131-5. doi: 10.1016/j.addr.2006.07.027. Epub 2006 Sep 26.

Cassette dosing pharmacokinetic studies for evaluation of ophthalmic drugs for posterior ocular diseases.用于评估治疗后部眼病的眼科药物的卡式给药药代动力学研究。

J Pharm Sci. 2008 Aug;97(8):3411-21. doi: 10.1002/jps.21188.

Transscleral drug delivery to the posterior eye: prospects of pharmacokinetic modeling.经巩膜给药至眼后段：药代动力学建模的前景

Adv Drug Deliv Rev. 2006 Nov 15;58(11):1164-81. doi: 10.1016/j.addr.2006.07.025. Epub 2006 Sep 16.

Nanocarriers for treatment of ocular neovascularization in the back of the eye: new vehicles for ophthalmic drug delivery.用于治疗眼后眼部新生血管形成的纳米载体：眼科药物递送的新载体。

Nanomedicine (Lond). 2015;10(13):2093-107. doi: 10.2217/nnm.15.47. Epub 2015 Jun 22.

Dangers of ocular instillation of medications.眼部滴注药物的风险。

West J Med. 1985 Sep;143(3):391.

Pediatric dosing considerations in ophthalmology--dosage adjustments based on aqueous humor volume ratio.眼科中的儿科用药考量——基于房水容积比的剂量调整

J Pediatr Ophthalmol. 1977 Jul-Aug;14(4):254-6.

Safety evaluation of ocular drug delivery formulations: techniques and practical considerations.眼部给药制剂的安全性评估：技术与实际考量

Toxicol Pathol. 2008 Jan;36(1):49-62. doi: 10.1177/0192623307310955.

引用本文的文献

Design and Characterization of Ocular Inserts Loaded with Dexamethasone for the Treatment of Inflammatory Ophthalmic Disease.用于治疗炎性眼病的载地塞米松眼用插入剂的设计与表征

Pharmaceutics. 2024 Feb 19;16(2):294. doi: 10.3390/pharmaceutics16020294.

Ocular Pharmacology and Toxicology of TRPV1 Antagonist SAF312 (Libvatrep).TRPV1 拮抗剂 SAF312（利伐曲班）的眼部药理学和毒理学。

Transl Vis Sci Technol. 2023 Sep 1;12(9):5. doi: 10.1167/tvst.12.9.5.

Biodegradable Thermosensitive PLGA-PEG-PLGA Polymer for Non-irritating and Sustained Ophthalmic Drug Delivery.可生物降解温敏性 PLGA-PEG-PLGA 聚合物用于非刺激性和持续的眼科药物传递。

AAPS J. 2019 Apr 24;21(4):59. doi: 10.1208/s12248-019-0326-x.

Challenges in the Polyene- and Azole-Based Pharmacotherapy of Ocular Fungal Infections.多烯类和唑类药物治疗眼部真菌感染的挑战。

J Ocul Pharmacol Ther. 2019 Jan/Feb;35(1):6-22. doi: 10.1089/jop.2018.0089. Epub 2018 Nov 8.

Ocular Drug Delivery Barriers-Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases.眼部给药屏障——纳米载体在眼前节眼部疾病治疗中的作用

Pharmaceutics. 2018 Feb 27;10(1):28. doi: 10.3390/pharmaceutics10010028.

Ocular delivery of proteins and peptides: Challenges and novel formulation approaches.蛋白质和肽类的眼部递药：挑战与新制剂方法。

Adv Drug Deliv Rev. 2018 Feb 15;126:67-95. doi: 10.1016/j.addr.2018.01.008. Epub 2018 Jan 13.

Recent advances in topical nano drug-delivery systems for the anterior ocular segment.眼前节局部纳米药物递送系统的最新进展

Ther Deliv. 2018 Feb;9(2):137-153. doi: 10.4155/tde-2017-0088.

Corneal delivery of besifloxacin using rapidly dissolving polymeric microneedles.利用快速溶解的聚合型微针进行贝西沙星角膜传递。

Drug Deliv Transl Res. 2018 Jun;8(3):473-483. doi: 10.1007/s13346-017-0470-8.

Anti-Toxoplasma activity and impact evaluation of lyophilization, hot molding process, and gamma-irradiation techniques on CLH-PLGA intravitreal implants.冻干、热成型工艺及γ射线辐照技术对CLH-PLGA玻璃体内植入物抗弓形虫活性及影响的评估

J Mater Sci Mater Med. 2016 Jan;27(1):10. doi: 10.1007/s10856-015-5621-1. Epub 2015 Dec 16.

Physiologically active hydrogel (in situ gel) of sparfloxacin and its evaluation for ocular retention using gamma scintigraphy.司帕沙星的生理活性水凝胶（原位凝胶）及其使用γ闪烁显像法对眼部滞留情况的评估

J Pharm Bioallied Sci. 2015 Jul-Sep;7(3):195-200. doi: 10.4103/0975-7406.160015.

本文引用的文献

Decrease in intraocular pressure in man by a carbonic anhydrase inhibitor, diamox; a preliminary report.碳酸酐酶抑制剂二氮嗪降低人体眼压的初步报告

Am J Ophthalmol. 1954 Jan;37(1):13-5. doi: 10.1016/0002-9394(54)92027-9.

Physicochemical determinants of drug diffusion across the conjunctiva, sclera, and cornea.药物跨结膜、巩膜和角膜扩散的物理化学决定因素。

J Pharm Sci. 1987 Aug;76(8):583-6. doi: 10.1002/jps.2600760802.

A physiologically based pharmacokinetic model for the intraocular distribution of pilocarpine in rabbits.

J Pharmacokinet Biopharm. 1981 Dec;9(6):653-77. doi: 10.1007/BF01070899.

Pharmacokinetics of fluorescein in the vitreous.荧光素在玻璃体中的药代动力学。

Invest Ophthalmol Vis Sci. 1981 Oct;21(4):542-9.

Effect of phenylephrine on aqueous humor flow.去氧肾上腺素对房水流出的影响。

Curr Eye Res. 1982;2(2):89-92. doi: 10.3109/02713688208997681.

Disposition of cyclophosphamide in the rabbit and human cornea.环磷酰胺在兔和人角膜中的处置情况。

Biopharm Drug Dispos. 1982 Jul-Sep;3(3):231-41. doi: 10.1002/bdd.2510030306.

Pharmacokinetics of the antineoplastic agent 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in the aqueous and vitreous of rabbit.抗肿瘤药物1,3-双(2-氯乙基)-1-亚硝基脲(BCNU)在兔眼房水和玻璃体中的药代动力学

Invest Ophthalmol Vis Sci. 1982 Aug;23(2):199-208.

Cefsulodin concentrations in rabbit eyes after intravenous and subconjunctival administration.

Ophthalmic Res. 1982;14(2):129-34. doi: 10.1159/000265184.

Disposition of topical flurbiprofen in normal and aphakic rabbit eyes.氟比洛芬滴眼液在正常及无晶状体兔眼中的分布情况。

Arch Ophthalmol. 1982 Apr;100(4):642-5. doi: 10.1001/archopht.1982.01030030644024.

Pharmacokinetics of topically applied ophthalmic drugs.局部应用眼科药物的药代动力学。

Surv Ophthalmol. 1982 Jan-Feb;26(4):207-18. doi: 10.1016/0039-6257(82)90081-9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验